Cannabis bioengineering generally involves the use of genetic modifications to scale up the production process of cannabis and its extracts. Cannabinoids such as THC, CBD, and several others present in the cannabis plant matrix only exist in small quantities. This makes it unfit for use on an industrial scale especially in terms of the pharmaceutical use of the product. Cannabinoids are majorly concentrated in trichomes which are short outgrowth on the cannabis bud. This makes the stem, stalk, leaves unusable in terms of getting the necessary cannabinoids. This apparent need led to the introduction of genetic modifications to cannabis cultivation.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…